The Latest in Conference Coverage

How Much MS Disease Activity Is Acceptable?

October 31, 2016

Multiple Sclerosis

Lipoic Acid Reduces Brain Atrophy in Secondary Progressive MS

October 31, 2016

Multiple Sclerosis

Genetic Variations May Affect Vitamin D Level and MS Relapse Rate

October 27, 2016

Multiple Sclerosis

Neuronal Protein Could Be a Blood Biomarker of MS

October 27, 2016

Multiple Sclerosis

Genetic risk score for low vitamin D may affect MS relapse rate

October 18, 2016

Multiple Sclerosis

Efficacy of Cladribine Tablets Continues After Conversion to MS

October 10, 2016

Multiple Sclerosis

Evaluation of Cortical Lesions Could Improve Diagnosis of MS

October 3, 2016

Multiple Sclerosis

Smoking, vitamin D deficiency linked to early MS disability

October 3, 2016

Multiple Sclerosis

Fluoxetine fails to slow progressive multiple sclerosis

October 3, 2016

Multiple Sclerosis

Neuronal protein could be multiple sclerosis blood biomarker

October 1, 2016

Multiple Sclerosis

Retinal Measurements Predict 10-Year Disability in MS

September 30, 2016

Multiple Sclerosis

Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?

September 30, 2016

Multiple Sclerosis

Clinical Considerations of New and Pending MS Treatments

September 30, 2016

Multiple Sclerosis

What Distinguishes MS From Its Mimics?

September 28, 2016

Multiple Sclerosis

Alemtuzumab, natalizumab found equally effective for relapsing-remitting MS

September 22, 2016

Multiple Sclerosis